Paediatric Consumer Health in the Czech Republic
PAEDIATRIC CONSUMER HEALTH IN THE CZECH REPUBLIC
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
the Birth Rate Is No Longer Amongst the Factors Driving Growth
Rising Demand for Herbal and All-natural Medicines
New Herbal Product Launches
Competitive Landscape
the Penetration of Private Label in Paediatric Consumer Health
Omega Pharma Withdraws Its Dermalex Repair Cream
Annabis Medical Announces Its Acquisition by Canopy Growth Corporation
Category Data
Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023
Executive Summary
Self-medication and Prevention See A Further Boost
Consumers' Confidence in Private Label Products Continues To Increase
Another Year of Growth in 2018
the Changing Face of Traditional Chemists/pharmacies
Distributors Continue To Bypass Some Pharmacies, Violating the New Law
An Even Stronger Performance in the Forecast Period
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Definitions
Sources
Summary 2 Research Sources
The birth rate in the Czech Republic saw no change in 2018, and only a marginal change is expected in the coming years. Nevertheless, the demand for OTC paediatric consumer health products continued to increase in 2018. The fact that children often suffer from acute short-term illnesses, such as chronic upper respiratory or ear infections, or gastrointestinal illness accompanied by vomiting and diarrhoea, or injury-related problems, together with the move of parents towards self-medication, drov...
Euromonitor International's Paediatric Consumer Health in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.